The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor / Zengliang Jin en European Neuropsychopharmacology, Año 2015 - Vol. 25 - No.4 (Abril)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No.4 (Abril) . - pp. 544-556 Título : The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor Tipo de documento: texto impreso Autores: Zengliang Jin, Autor ; Nana Gao, Autor ; Xiaorong Li, Autor Fecha de publicación: 2021 Artículo en la página: pp. 544-556 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Yuanzhi-1, Inhibidores de triple recaptación, Modelos animales Resumen: Triple reuptake inhibitors that block dopamine transporters (DATs), norepinephrine transporters (NETs), and serotonin transporters (SERTs) are being developed as a new class of antidepressants that might have better efficacy and fewer side effects than traditional antidepressants. Link: ./index.php?lvl=notice_display&id=26802 [artículo] The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor [texto impreso] / Zengliang Jin, Autor ; Nana Gao, Autor ; Xiaorong Li, Autor . - 2021 . - pp. 544-556. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.4 (Abril) . - pp. 544-556 Palabras clave: Antidepresivos, Yuanzhi-1, Inhibidores de triple recaptación, Modelos animales Resumen: Triple reuptake inhibitors that block dopamine transporters (DATs), norepinephrine transporters (NETs), and serotonin transporters (SERTs) are being developed as a new class of antidepressants that might have better efficacy and fewer side effects than traditional antidepressants. Link: ./index.php?lvl=notice_display&id=26802

---

1 (1 - 1 / 1)